首页> 外文期刊>Translational Oncology >Identification of a Novel Fusion Gene, FAM174A-WWC1, in Early-Onset Colorectal Cancer: Establishment and Characterization of Four Human Cancer Cell Lines from Early-Onset Colorectal Cancers
【24h】

Identification of a Novel Fusion Gene, FAM174A-WWC1, in Early-Onset Colorectal Cancer: Establishment and Characterization of Four Human Cancer Cell Lines from Early-Onset Colorectal Cancers

机译:新型的融合基因,FAM174A-WWC1,在早发性大肠癌中的鉴定:从早发性大肠癌的四种人类癌细胞系的建立和表征

获取原文
           

摘要

Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide and represents the second most common cause of all cancer-related deaths in Korea. Although epidemiological data indicate a sharp increase in the incidence of CRC among individuals older than 50?years, more than 10% of CRCs occur before reaching 50. These are known as early-onset CRCs (EOCRCs) and are likely to be suggestive of hereditary predisposition. However, known familial CRC syndromes account for only 20% of genetic aberrations of EOCRC, and the remaining 80% are still in question. Therefore, we aimed to establish reproducible biological resources and contribute to expand the mutation database of EOCRC. Four cell lines derived from the original tumor mass of CRC patients diagnosed under age 30?years were established, and next-generation sequencing technique was used to identify the genetic features of EOCRC. We have identified one novel fusion gene, FAM174A-WWC1, and analyzed its functional role. The induction of FAM174A-WWC1 to normal fibroblast caused alternations in cellular morphology as well as intercellular expression of E-cadherin and N-cadherin. Moreover, WWC1 carrying the fused FAM174A domain not only abrogated the membrane expression of YAP1 but also significantly increased the levels of nucleic YAP1. As a result, the FAM174A-WWC1 expression increased the oncogenic capacity and invasiveness of normal fibroblasts, which suggests its role as a potential driver mutation of EOCRC.
机译:结肠直肠癌(CRC)是全球诊断出的第三大最常见癌症,是韩国所有与癌症相关的死亡中第二大最常见的原因。尽管流行病学数据表明,年龄在50岁以上的人中CRC的发病率急剧上升,但超过10%的CRC在50岁之前就已发生。这些被称为早期CRC(EOCRC),可能暗示着遗传性易感性。但是,已知的家族性CRC综合征仅占EOCRC遗传畸变的20%,其余80%仍存在疑问。因此,我们旨在建立可再生的生物资源,并为扩展EOCRC的突变数据库做出贡献。建立了从30岁以下被诊断为CRC患者的原始肿瘤块的四个细胞系,并使用下一代测序技术来鉴定EOCRC的遗传特征。我们已经确定了一个新的融合基因,FAM174A-WWC1,并分析了其功能作用。 FAM174A-WWC1对正常成纤维细胞的诱导导致细胞形态以及E-cadherin和N-cadherin的细胞间表达发生变化。此外,携带融合的FAM174A结构域的WWC1不仅废除了YAP1的膜表达,而且显着增加了核酸YAP1的水平。结果,FAM174A-WWC1表达增加了正常成纤维细胞的致癌能力和侵袭性,这表明它是EOCRC的潜在驱动突变体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号